Rebecca Shatsky: Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009
Rebecca Shatsky shared a post on X, about recent paper published in The Lancet:
”Well this is excellent news!
Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials – The Lancet.”
Source: Rebecca Shatsky/X
Rebecca Shatsky is a member of the NCCN guideline panel for Genetic/High-Risk Assessment of Breast, Ovarian, and Pancreatic Cancer, as well as the panel for the treatment of Cancer-Associated Pain. Her research has been published in prestigious journals, including JAMA Oncology, Cancer Cell, and Molecular Cancer Therapeutics. In addition to her clinical and research roles, Dr. Shatsky is an active member of both the American Association for Cancer Research and the American Society of Clinical Oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023